Position in NBIX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,831,472
+$2,147,358 QoQ
Shares Held
16,800
+139.4% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#271
of 772 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026USS Investment Management Ltd holds $9,585,449 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (29.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
93,988 | $6,753,977 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
16,800 | $2,831,472 |
All Filings in NBIX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,831,472 | 16,800 | Shares | Sole | 2026-08-11 | |
| 2022-06-30 | $684,114 | 7,018 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $786,187 | 8,386 | Shares | Sole | 2022-07-18 | |
| 2021-12-31 | $1,767,021 | 20,747 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,989,844 | 20,747 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $528,934 | 5,435 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $528,553 | 5,435 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $520,944 | 5,435 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $522,629 | 5,435 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $663,070 | 5,435 | Shares | Sole | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||